Internet
Media6 Degrees
Media6 Degrees of New York closed a $9 million Series A round led by U.S. Venture Partners of Menlo Park, Calif. The financing also included Contour Venture Partners and Coriolis Ventures, both of New York, as well as several angel investors. The company's technology provides marketers with targeted audiences using social graph data. Media6 claims its algorithms and methods connect a brand's customers with targeted user segments.
Software
Ryma Technology
Business intelligence software developer Ryma Technology Solutions Inc. of Montreal has closed a $7 million Series B round. New investor iNovia Capital of Montreal led the funding, with participation from the returning Novacap, also of Montreal. Ryma's technology is designed to give a company's executives an overview of their entire business.
Semiconductors
Xelerated
Swedish telecommunications chip developer Xelerated AB has received $13 million in a new investment round led by the Sixth Swedish National Pension Fund. Joining the round were other existing investors Accel Partners, Amadeus Capital Partners and Atlas Ventures, all of London; and Alta Partners of San Francisco. Total funding in the eight-year-old company is now about $90 million, enabling the company to survive as one of the last developers of proprietary silicon for carrier class routers and switches. The deal follows the largest funding round in the company's history, when Sixth Swedish and Amadeus joined in a $23 million deal to carry the company into volume production and its first significant revenues. --Clifford Carlsen
Medical devices
Vapotherm
Vapotherm Inc., a Stevensville, Md., developer of high-flow respiratory therapy products, has secured $20.5 million in financing. GE Asset Management of Stamford, Conn., led the financing, with participation by Cross Creek Capital of Salt Lake City and Integral Capital Partners of Menlo Park, Calif, Exisitng investors QuestMark Partners of Baltimore and Kaiser Permanente Ventures of Oakland, Calif., also participated. Vapotherm products are used in neonatal, pediatric and adult applications in hospitals. The financing will go towards new product development, expanding sales and the launch of the company's latest acute care device.
Continue reading below
